See more : Kapston Services Limited (KAPSTON.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Teladoc Health, Inc. (4LL.F) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Teladoc Health, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- EXEL Industries SA (EXE.PA) Income Statement Analysis – Financial Results
- Jyoti CNC Automation Limited (JYOTICNC.NS) Income Statement Analysis – Financial Results
- Tlou Energy Limited (TOU.AX) Income Statement Analysis – Financial Results
- Right On Brands, Inc. (RTON) Income Statement Analysis – Financial Results
- Benesse Holdings, Inc. (BSEFY) Income Statement Analysis – Financial Results
Teladoc Health, Inc. (4LL.F)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.teladochealth.com
About Teladoc Health, Inc.
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.60B | 2.41B | 2.03B | 1.09B | 553.31M | 417.91M | 233.28M | 123.16M | 77.38M | 43.53M | 19.91M |
Cost of Revenue | 760.03M | 743.99M | 650.26M | 390.83M | 184.47M | 128.74M | 61.62M | 31.97M | 21.04M | 9.93M | 4.19M |
Gross Profit | 1.84B | 1.66B | 1.38B | 703.13M | 368.84M | 289.17M | 171.66M | 91.19M | 56.34M | 33.60M | 15.72M |
Gross Profit Ratio | 70.80% | 69.09% | 68.01% | 64.27% | 66.66% | 69.20% | 73.58% | 74.04% | 72.81% | 77.19% | 78.97% |
Research & Development | 348.52M | 333.63M | 311.88M | 164.94M | 64.64M | 54.37M | 34.46M | 21.82M | 14.21M | 7.57M | 3.53M |
General & Administrative | 464.66M | 449.86M | 438.01M | 506.68M | 164.46M | 118.78M | 81.27M | 52.69M | 54.84M | 19.62M | 8.77M |
Selling & Marketing | 902.63M | 850.71M | 667.31M | 380.20M | 174.61M | 144.26M | 95.65M | 60.96M | 38.21M | 19.23M | 8.53M |
SG&A | 1.37B | 1.30B | 1.11B | 886.88M | 339.07M | 263.05M | 176.91M | 113.65M | 93.06M | 38.86M | 17.30M |
Other Expenses | 375.12M | -859.00K | 5.09M | -545.00K | 342.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 2.09B | 1.89B | 1.62B | 1.12B | 442.66M | 355.14M | 233.85M | 146.89M | 112.13M | 48.75M | 21.59M |
Cost & Expenses | 2.85B | 2.63B | 2.27B | 1.51B | 627.13M | 483.87M | 295.48M | 178.86M | 133.17M | 58.68M | 25.78M |
Interest Income | 46.78M | 12.67M | 776.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 22.28M | 9.27M | 80.37M | 60.50M | 29.01M | 26.11M | 17.49M | 2.59M | 2.20M | 1.50M | 56.00K |
Depreciation & Amortization | 351.32M | 270.64M | 219.62M | 78.09M | 44.95M | 35.60M | 19.10M | 8.27M | 4.86M | 2.32M | 754.00K |
EBITDA | 154.00M | -13.37B | -83.89M | -437.96M | -35.15M | -35.25M | -70.42M | -62.85M | -50.92M | -12.83M | -5.12M |
EBITDA Ratio | 5.92% | 559.62% | -0.70% | -31.09% | -5.22% | -7.27% | -18.48% | -38.52% | -65.80% | -29.48% | -25.70% |
Operating Income | -248.55M | -13.65B | -265.63M | -506.42M | -80.44M | -70.85M | -75.39M | -62.66M | -55.79M | -15.15M | -5.87M |
Operating Income Ratio | -9.55% | -567.27% | -13.07% | -46.29% | -14.54% | -16.95% | -32.32% | -50.88% | -72.09% | -34.81% | -29.48% |
Total Other Income/Expenses | 28.95M | -10.13M | -119.03M | -69.57M | -29.01M | -26.11M | -31.61M | -11.04M | -2.20M | -1.50M | -56.00K |
Income Before Tax | -219.61M | -13.66B | -384.66M | -575.99M | -109.46M | -96.97M | -107.01M | -73.71M | -57.98M | -16.65M | -5.93M |
Income Before Tax Ratio | -8.44% | -567.69% | -18.92% | -52.65% | -19.78% | -23.20% | -45.87% | -59.85% | -74.93% | -38.25% | -29.76% |
Income Tax Expense | 760.00K | -3.81M | 44.14M | -90.86M | -10.59M | 118.00K | -225.00K | 510.00K | 36.00K | 388.00K | 94.00K |
Net Income | -220.37M | -13.66B | -428.79M | -485.14M | -98.86M | -97.08M | -106.78M | -74.22M | -58.02M | -17.04M | -6.02M |
Net Income Ratio | -8.47% | -567.53% | -21.09% | -44.35% | -17.87% | -23.23% | -45.77% | -60.26% | -74.98% | -39.14% | -30.24% |
EPS | -1.36 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 | -1.93 | -1.75 | -2.91 | -0.62 | -0.22 |
EPS Diluted | -1.36 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 | -1.93 | -1.75 | -2.91 | -0.62 | -0.22 |
Weighted Avg Shares Out | 162.17M | 161.46M | 156.94M | 90.51M | 71.84M | 65.84M | 55.43M | 42.33M | 19.92M | 27.61M | 27.61M |
Weighted Avg Shares Out (Dil) | 162.17M | 161.46M | 156.94M | 90.51M | 71.84M | 65.84M | 55.43M | 42.33M | 19.92M | 27.61M | 27.61M |
Source: https://incomestatements.info
Category: Stock Reports